Braxia Scientific Corp

Braxia Scientific Corp. is a medical research company, which engages in owning and operating multidisciplinary clinics and providing treatment for mental health disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The firm is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The firm has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.